title: PHARMAC's updated guidelines for cost-utility analyses, with new QALYs per $1M metric.
authors.forename: Rachel
authors.initials: R
authors.lastname: Grocott
authors.forename: Scott
authors.initials: S
authors.lastname: Metcalfe
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D017059:Models, Econometric; D009313:National Health Programs / Q000191:economics*; D009520:New Zealand; D017063:Outcome Assessment, Health Care / Q000191:economics / Q000379:methods*; D010593:Pharmaceutical Services / Q000191:economics*; D019057:Quality-Adjusted Life Years